USA - NASDAQ:LHCG - US50187A1079 - Common Stock
The current stock price of LHCG is 169.81 USD. In the past month the price increased by 3.28%. In the past year, price increased by 25.82%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.36 | 98.69B | ||
| CI | THE CIGNA GROUP | 9.49 | 71.98B | ||
| LH | LABCORP HOLDINGS INC | 16.87 | 22.18B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.15 | 20.90B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.07 | 19.17B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.77B | ||
| DVA | DAVITA INC | 13.17 | 8.69B | ||
| HIMS | HIMS & HERS HEALTH INC | 68.48 | 8.36B | ||
| CHE | CHEMED CORP | 19.8 | 6.35B | ||
| RDNT | RADNET INC | 197.76 | 5.78B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.37 | 5.67B | ||
| OPCH | OPTION CARE HEALTH INC | 19.07 | 4.61B |
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company is headquartered in Lafayette, Louisiana and currently employs 16,000 full-time employees. The company went IPO on 2005-06-09. The firm operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services and Healthcare Innovations (HCI). The Home Health Service segment offers a range of services, including wound care and dressing changes, pain management, pharmaceutical administration, skilled observation and assessment and patient education. The Hospice segment offers a range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home and Community-Based Services segment, services are performed by skilled nursing and paraprofessional personnel, and include assistance with activities of daily living to the elderly, chronically ill, and disabled patients. HCI segment reports on its developmental activities outside its other business segments.
LHC GROUP INC
901 Hugh Wallis Road South
Lafayette LOUISIANA 70508 US
CEO: Keith G. Myers
Employees: 16000
Phone: 13372331307.0
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company is headquartered in Lafayette, Louisiana and currently employs 16,000 full-time employees. The company went IPO on 2005-06-09. The firm operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services and Healthcare Innovations (HCI). The Home Health Service segment offers a range of services, including wound care and dressing changes, pain management, pharmaceutical administration, skilled observation and assessment and patient education. The Hospice segment offers a range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home and Community-Based Services segment, services are performed by skilled nursing and paraprofessional personnel, and include assistance with activities of daily living to the elderly, chronically ill, and disabled patients. HCI segment reports on its developmental activities outside its other business segments.
The current stock price of LHCG is 169.81 USD. The price increased by 0.47% in the last trading session.
LHCG does not pay a dividend.
LHCG has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
13 analysts have analysed LHCG and the average price target is 176.8 USD. This implies a price increase of 4.12% is expected in the next year compared to the current price of 169.81.
LHC GROUP INC (LHCG) has a market capitalization of 5.27B USD. This makes LHCG a Mid Cap stock.
LHC GROUP INC (LHCG) will report earnings on 2023-05-02.
ChartMill assigns a technical rating of 7 / 10 to LHCG. When comparing the yearly performance of all stocks, LHCG is one of the better performing stocks in the market, outperforming 87.53% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to LHCG. LHCG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months LHCG reported a non-GAAP Earnings per Share(EPS) of 4.39. The EPS decreased by -25.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.73% | ||
| ROA | 2.16% | ||
| ROE | 3.94% | ||
| Debt/Equity | 0.46 |
13 analysts have analysed LHCG and the average price target is 176.8 USD. This implies a price increase of 4.12% is expected in the next year compared to the current price of 169.81.
For the next year, analysts expect an EPS growth of -22.68% and a revenue growth 4.9% for LHCG